Top

Published in:

01-02-2013 | Literatur kommentiert

Resektion plus adjuvante Chemotherapie verbessert Überleben beim fortgeschrittenen Pankreaskarzinom

Authors: Prof. Dr. S.E. Combs, J. Werner

Published in: Strahlentherapie und Onkologie | Issue 2/2013

Auszug

Ren F, Xu YC, Wang HX et al (2012) Adjuvant chemotherapy, with or without postoperative radiotherapy, for resectable advanced pancreatic adenocarcinoma: continue or stop? Pancreatology 12:162–169 …

Hartwig W, Werner J, Buchler MW (2012) Prognosis of resected pancreatic cancer: is the refined resection margin status dispensable? Langenbecks Arch Surg 397:859–860PubMedCrossRef

Hartwig W, Hackert T, Hinz U et al (2011) Pancreatic cancer surgery in the new millennium: better prediction of outcome. Ann Surg 254:311–319PubMedCrossRef

Hartwig W, Hackert T, Hinz U et al (2009) Multivisceral resection for pancreatic malignancies: risk-analysis and long-term outcome. Ann Surg 250:81–87PubMedCrossRef

Strobel O, Berens V, Hinz U et al (2012) Resection after neoadjuvant therapy for locally advanced, „unresectable“ pancreatic cancer. Surgery 152(3 Suppl1):539–542CrossRef

Gillen S, Schuster T, Meyer Zum BC et al (2010) Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med 7:e1000267PubMedCrossRef

Adler G, Seufferlein T, Bischoff SC et al (2007) S3-Guidelines „Exocrine pancreatic cancer“ 2007. Z Gastroenterol 45:487–523PubMedCrossRef

Oettle H, Post S, Neuhaus P et al (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297:267–277PubMedCrossRef

Neoptolemos JP, Stocken DD, Friess H et al (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350:1200–1210PubMedCrossRef

10.

Stocken DD, Buchler MW, Dervenis C et al (2005) Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer 92:1372–1381PubMedCrossRef

11.

Stocken DD, Buchler MW, Dervenis C et al (2005) Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer 92:1372–1381PubMedCrossRef

12.

Kalser MH, Ellenberg SS (1985) Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120:899–903PubMedCrossRef

13.

Klinkenbijl JH, Jeekel J, Sahmoud T et al (1999) Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 230:776–782PubMedCrossRef

14.

Penberthy DR, Rich TA, Adams RB (2003) Postoperative adjuvant therapy for pancreatic cancer. Semin Surg Oncol 21:256–260PubMedCrossRef

15.

Morganti AG, Massaccesi M, La Torre G et al (2010) A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. Ann Surg Oncol 17:194–205PubMedCrossRef

16.

Habermehl D, Kessel K, Welzel T et al (2012) Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer. Radiat Oncol 7:28PubMedCrossRef

Title: Resektion plus adjuvante Chemotherapie verbessert Überleben beim fortgeschrittenen Pankreaskarzinom
Authors: Prof. Dr. S.E. Combs
J. Werner
Publication date: 01-02-2013
Publisher: Springer-Verlag
Published in: Strahlentherapie und Onkologie / Issue 2/2013
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-012-0268-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Resektion plus adjuvante Chemotherapie verbessert Überleben beim fortgeschrittenen Pankreaskarzinom

Auszug

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Auszug

Please log in to get access to this content

Other articles of this Issue 2/2013

Multiple malignancies in a single patient

Lokale Kontrolle bei T3-Rektumkarzinomen

Abstracts der 29. Jahrestagung der Österreichischen Gesellschaft für Radioonkologie, Radiobiologie und Medizinische Radiophysik (ÖGRO 2012)

Endocrine and visual function after fractionated stereotactic radiotherapy of perioptic tumors

Karzinom des Ösophagus und des gastroösophagealen Übergangs

Intraoperative EBRT and resection for renal cell carcinoma